Position in ANL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,053,170
New position
Shares Held
2,897,857
first reported quarter
Ownership
4.50%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. ANL ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
885,500 | $285,299,245 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $160,013,416 | |
| 3 | EYPT |
EyePoint, Inc.
|
8,265,000 | $106,535,850 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
3,260,000 | $102,690,000 | |
| 5 | ERAS |
Erasca, Inc.
|
5,800,000 | $93,844,000 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
2,957,521 | $92,540,832 | |
| 7 | ALMS |
Alumis Inc.
|
3,949,241 | $87,001,779 | |
| 8 | ABVX |
Abivax S.A.
|
760,000 | $84,626,000 |
All Filings in ANL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,053,170 | 2,897,857 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||